Corvex Operating Cash Flow decreased by 89.7% to -$4.29M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.3%, from -$4.30M to -$4.29M. Over 3 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a -11.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$4.05M | -$4.05M | -$4.05M | -$5.78M | -$6.37M | -$6.08M | -$7.88M | -$6.96M | -$5.25M | -$4.13M | -$8.17M | -$5.68M | -$4.56M | -$4.30M | -$3.10M | -$1.61M | -$2.26M | -$4.29M |
| QoQ Change | — | +0.0% | +0.0% | -42.9% | -10.2% | +4.6% | -29.7% | +11.7% | +24.6% | +21.3% | -97.8% | +30.6% | +19.7% | +5.5% | +28.1% | +48.0% | -40.5% | -89.7% |
| YoY Change | — | — | — | — | -57.5% | -5.2% | -23.7% | — | — | +32.1% | -3.7% | +18.5% | +13.2% | -4.2% | +62.1% | +71.6% | +50.4% | +0.3% |